Santen Pharm 1H Group Net Income 9.90B Yen 4536 JP

Santen Pharm (4536) announced first-half group earnings for the period ended Sept. 30. Figures other than earnings per share are in millions of yen.

================================================================================

Operating Current Net Earnings

Revenue Profit Profit Income Per Share ================================================================================ First-Half Results 56789.00 14570.00 15050.00 9905.00 113.70 Year-Earlier Period 53914.00 14112.00 14490.00 9272.00 108.94 Versus Results 5.30% 3.20% 3.90% 6.80% 4.00% Full-Year Estimates 116000.00 30000.00 30500.00 20500.00 239.95 ================================================================================

To contact the editor responsible for this story: Teo Chian Wei at +81-3-3201-3623 or cwteo@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.